Showing 581 - 600 results of 18,071 for search '(( e fold decrease ) OR ( 50 ((((nn decrease) OR (we decrease))) OR (a decrease)) ))', query time: 0.56s Refine Results
  1. 581
  2. 582
  3. 583

    Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial by Michel Mandro (2637532)

    Published 2020
    “…<div><p>Introduction</p><p>Recent findings from onchocerciasis-endemic foci uphold that increasing ivermectin coverage reduces the epilepsy incidence, and anecdotal evidence suggests seizure frequency reduction in persons with onchocerciasis-associated epilepsy, when treated with ivermectin. We conducted a randomized clinical trial to assess whether ivermectin treatment decreases seizure frequency.…”
  4. 584
  5. 585

    2‑Aminobenzoxazole Derivatives as Potent Inhibitors of the Sphingosine-1-Phosphate Transporter Spinster Homolog 2 (Spns2) by Ariel L. Burgio (15069256)

    Published 2023
    “…To develop more potent compounds, we initiated a structure–activity relationship study that identified 2-aminobenzoxazole as a viable scaffold. …”
  6. 586
  7. 587
  8. 588
  9. 589
  10. 590
  11. 591
  12. 592
  13. 593
  14. 594
  15. 595
  16. 596

    Dietary Restriction Induces Gluconeogenic Gene <i>pck-2</i> Expression via DAF-16, and <i>pck-2</i> Expression is Needed for DR-associated Healthspan Benefits. by Brian Onken (86790)

    Published 2020
    “…<p>(A) Representative wild-type animals expressing a GFP transcriptional reporter for <i>pck-2</i> (<i>pck-2</i> promoter GFP fusion, lacking <i>pck-2</i> coding sequences) under <i>ad libitum</i> (AL) or dietary restricted (DR) conditions, day 4 of life. …”
  17. 597
  18. 598
  19. 599
  20. 600